Edition:
United Kingdom

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

13.86USD
18 Oct 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$13.86
Open
$16.10
Day's High
$16.10
Day's Low
$13.07
Volume
367,365
Avg. Vol
152,007
52-wk High
$31.69
52-wk Low
$12.51

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.609
Mar '18 0.00 -0.432
FY 2017 Dec '17 0.00 -0.371
Sep '17 0.00 -0.235
Jun '17 0.00 -0.246
Mar '17 0.00 -0.184
FY 2016 Dec '16 0.00 -0.134
Sep '16 0.00 -0.146
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 0.00 0.00 0.00 --
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 4 -0.74 -0.64 -0.90 --
Quarter Ending Mar-19 3 -0.73 -0.70 -0.77 --
Year Ending Dec-18 5 -2.34 -1.85 -2.75 --
Year Ending Dec-19 5 -2.71 -1.97 -3.24 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.92 33.69
P/E High - Last 5 Yrs. -- 40.54 45.21
P/E Low - Last 5 Yrs. -- 23.30 23.79
Beta -- 0.89 0.88
Price to Sales (TTM) -- 3.94 5.82
Price to Book (MRQ) -- 4.77 4.89
Price to Tangible Book (MRQ) -- 5.61 6.52
Price to Cash Flow (TTM) -- 22.57 22.95
% Owned Institutions -- 1.13 2.14

Dividends

  Company industry sector
Dividend Yield -- 1.58 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.41 5.39
Payout Ratio(TTM) -- 46.20 43.91

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.20 8.02
Sales (TTM) vs TTM 1 Yr. Ago -- 4.64 5.75
Sales - 5 Yr. Growth Rate -- 9.69 9.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 19.84 23.65
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.96 10.95
Capital Spending - 5 Yr. Growth Rate -- 15.10 14.90

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.25
Current Ratio (MRQ) -- 2.97 3.05
LT Debt to Equity (MRQ) -- 9.93 12.73
Total Debt to Equity (MRQ) -- 13.96 17.15
Interest Coverage (TTM) -- 41.56 37.58

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.19 54.90
Gross Margin - 5 Yr. Avg. -- 52.30 52.43
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.47 11.08
Operating Margin (TTM) -- 14.32 4.31
Operating Margin - 5 Yr. Avg. -- 14.35 6.43
Pre-Tax Margin (TTM) -- 14.86 5.36
Pre-Tax Margin - 5 Yr. Avg. -- 14.80 6.86
Net Profit Margin (TTM) -- 11.08 1.64
Net Profit Margin - 5 Yr. Avg. -- 11.07 3.11
Effective Tax Rate (TTM) -- 23.36 23.24
Effective Tax Rate - 5 Yr. Avg. -- 23.60 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 911,321,905 810,573,943
Net Income/Employee (TTM) -- 107,240,547 95,338,757
Receivable Turnover (TTM) -- 5.62 5.77
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) -- 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.37 10.92
Return on Assets - 5 Yr. Avg. -- 12.61 12.03
Return on Investment (TTM) -- 14.76 14.30
Return on Investment - 5 Yr. Avg. -- 16.44 15.63
Return on Equity (TTM) -- 16.26 16.03
Return on Equity - 5 Yr. Avg. -- 17.51 16.90

Performance for Apellis Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 23
13 Week -- -- -- 33
26 Week -- -- -- 28
52 Week -- -- -- 12
YTD -- -- -- 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 58.81%
# of Holders: 117
Total Shares Held: 33,037,040
3 Mo. Net Change: 144,855
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 15
# Reduced Positions: 1
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.